UK Triptan Switch Considered As MHRA Seeks Comment On Imitrex, Zomig

UK consumers seeking a triptan for migraine treatment will be questioned by a pharmacist on their history of cardiovascular and cerebrovascular disease prior to purchase if sumatriptan or zolmitriptan are approved for nonprescription sale in the country

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography